You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
25 March 2019
TRIGR Therapeutics Completes $14 Million Seed Round and Provides Phase 1a Clinical Update on its Lead Bispecific Oncology Candidate, TR009
